EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification and validation of ATP6V1G1-regulated phosphorylated proteins in hepatocellular carcinoma

Yi Zhang, Liuyi Lu, Mingxing Chen, Jiaqi Nie, Xue Qin, Huaping Chen iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0310037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Yi Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education Nanning, The First Affiliated Ho…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Vacuolar Proton-Translocating ATPases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Youth Science Foundation of Guangxi Medical University, Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

V-ATPase Subunit G1 (ATP6V1G1) is one of the subunits of Vacuolar ATPases. Previous studies have indicated that ATP6V1G1 plays important roles in hepatocellular carcinoma (HCC) and is associated with HCC progression. However, the effect of ATP6V1G1 in HCC requires further elucidation. The aim of the present study was to explore the roles of ATP6V1G1 in HCC and further decipher the detailed mechanism. To identify the phosphorylated proteins regulated by ATP6V1G1 in HCC, phosphoproteomics and LC-MS/MS analysis were performed on HepG2 with overexpression of ATP6V1G1 and empty vector. Western blotting was applied to validate the differentially expressed phosphorylated proteins (DEPPs). As a result, 163 DEPPs were identified by proteomics; two up-regulated phosphorylated proteins (p-RPS6(Ser235)) and (p-SQSTM1(Ser272)) and two down-regulated phosphorylated proteins (p-PDPK1(Ser241)) and (p-EEF2 (Ser57)) were validated. Taken together, this study highlighted the potential impact of ATP6V1G1 on tumor progression, which may be beneficial to liver cancer related basic research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsVacuolar Proton-Translocating ATPasesHumansPhosphorylationHep G2 CellsProteomicsTandem Mass SpectrometryGene Expression Regulation, Neoplastic

Substanzen

Vacuolar Proton-Translocating ATPases

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education Nanning, The First Affiliated Hospital of Guangxi Medical University, Guangxi, China.
  • Department of Clinical Laboratory, Guangxi International Zhuang Medicine Hospital, Nanning, Guangxi, China.
  • Department of Clinical Laboratory, Guangxi Maternal and Child Health Hospital, Nanning, Guangxi, China.

ORCID-Profile: Huaping Chen

Förderung

  • Youth Science Foundation of Guangxi Medical University
  • Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Y., Lu, L., Chen, M., Nie, J., Qin, X., & Chen, H. (2024). Identification and validation of ATP6V1G1-regulated phosphorylated proteins in hepatocellular carcinoma. PLOS ONE. https://doi.org/10.1371/journal.pone.0310037

Vancouver

Zhang Y, Lu L, Chen M, Nie J, Qin X, Chen H. Identification and validation of ATP6V1G1-regulated phosphorylated proteins in hepatocellular carcinoma. PLOS ONE. 2024. doi:10.1371/journal.pone.0310037

BibTeX
@article{Zhang2024,
  author = {Zhang, Yi and Lu, Liuyi and Chen, Mingxing and Nie, Jiaqi and Qin, Xue and Chen, Huaping},
  title = {Identification and validation of ATP6V1G1-regulated phosphorylated proteins in hepatocellular carcinoma},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0310037}
}
Kostenlos starten →